We are closely monitoring the COVID-19 outbreak and plan to continue shipping orders as usual. Read more about our business continuity plan »
What We Do
Deliver answers more effectively by using alternative, non-mammalian model organisms in early biological and biomedical research.
The InVivo Biosystems Technology provides the deep insights you need to make a go/no-go decision. Our data analysis and focused team of experts will also help you to understand the results and identify alternate routes and hypotheses you may not have seen previously.
Who We Serve
InVivo Biosystems provides essential analytical services to enable pharmaceutical, nutraceutical, biotechnology companies and research institutions around the globe accelerate their research and drug discovery efforts.
The InVivo Biosystems Technology provides the deep insights you need to make a go/no-go decision. Our data analysis and focused team of experts will also help you to understand the results and identify alternate routes and hypotheses you may not have seen previously.
What would you like to do?
Modify
Genome-edited C. elegans or zebrafish built to your specification.
Available Services:
C. elegans Genome-Editing | Zebrafish Genome-Editing
Humanized Models | Co-CRISPR Screening Kit
Prepare
Start critical first step in your experiment with worm-prep reagents & tools.
Featured Reagents:
NemaGel | C. elegans Lysis Kit
PCR Master Mix | Genotyping Reagent Bundle
Measure
Visualize, measure C. elegans behavior and collect phenotypic output.
Featured Instruments:
Nema Imager | C. elegans Synchronizer
ScreenChip™ System | wMicroTracker
In-Vivo Analytical Services
Shorten your timeline using the turn-key service to test your hypothesis or prove your concept.
Available Services:
Lifespan & Healthspan Analysis | In Vivo Toxicity Testing
Custom In Vivo Testing
What's New
Sample Report
Download our sample data report to see an example dataset you would receive if you partnered with us.
Case Study
Case study highlighting how the InVivo Biosystems Technology was used to examine 3 variants of STXBP1 in order to better understand each variant’s status as pathogenic or benign and to outline a phenotype-based model of the variant landscape.
Case Study
A discussion highlighting the InVivo Biosystems methodology using ACDY5 as a case study.
Latest Posts
Seventeen Minutes of Science: Virology & World Health (Episode 2)
6 things that can go wrong while making your Zebrafish CRISPR Knock-In
NemaMetrix Expands Business to Capitalize on In-vivo Solutions to Help Speed Testing for Critical Disease Therapeutics
Stay Informed & Up-to-date
The InVivo Biosystems Newsletter is delivered to your inbox bi-weekly, giving you all of the latest company updates, industry news, and more. Read our latest newsletter ».
READY TO GET STARTED?
Ready to connect with us to learn more about working with our company or our technology?